EMA-话题@MedSci

#EMA#

580篇内容 | 2462人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317413, encodeId=85e3131e413ea, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：输血依赖性地中海贫血幼童：早期开始去铁酮治疗是否安全有效？, objectType=article, longId=144711, objectId=969d144e1116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=969d144e1116, replyNumber=0, likeNumber=81, createdTime=2018-07-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=969d144e1116, moduleTitle=Am J Hematol：输血依赖性地中海贫血幼童：早期开始去铁酮治疗是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=969d144e1116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317412, encodeId=870d131e4123e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, objectType=article, longId=144692, objectId=895114469266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=895114469266, replyNumber=0, likeNumber=66, createdTime=2018-07-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=895114469266, moduleTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=895114469266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317411, encodeId=c493131e4118a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, objectType=article, longId=144543, objectId=35051445433e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35051445433e, replyNumber=0, likeNumber=88, createdTime=2018-07-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35051445433e, moduleTitle=Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35051445433e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317410, encodeId=d0ca131e4105d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人, objectType=article, longId=144542, objectId=f8ec1445427a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ec1445427a, replyNumber=0, likeNumber=72, createdTime=2018-07-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ec1445427a, moduleTitle=Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ec1445427a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317409, encodeId=52bd131e409de, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：地塞米松能否改善强化化疗急性髓细胞白血病患者的结局？, objectType=article, longId=144541, objectId=3a9814454161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a9814454161, replyNumber=0, likeNumber=67, createdTime=2018-07-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a9814454161, moduleTitle=Haematologica：地塞米松能否改善强化化疗急性髓细胞白血病患者的结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a9814454161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317408, encodeId=63bc131e408d9, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, objectType=article, longId=144538, objectId=cc1d14453882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d14453882, replyNumber=0, likeNumber=60, createdTime=2018-07-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d14453882, moduleTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d14453882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317407, encodeId=2717131e40739, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险, objectType=article, longId=142572, objectId=f2021425e29a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2021425e29a, replyNumber=0, likeNumber=75, createdTime=2018-07-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2021425e29a, moduleTitle=Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2021425e29a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317406, encodeId=26b0131e40699, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, objectType=article, longId=141566, objectId=d1de1415660b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1de1415660b, replyNumber=0, likeNumber=16, createdTime=2018-06-26, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1de1415660b, moduleTitle=Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1de1415660b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317405, encodeId=151a131e405cc, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：CP-CML患者：伊马替尼一线治疗后尼洛替尼怎么样？, objectType=article, longId=141184, objectId=8345141184b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8345141184b7, replyNumber=0, likeNumber=89, createdTime=2018-06-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8345141184b7, moduleTitle=Br J Haematol：CP-CML患者：伊马替尼一线治疗后尼洛替尼怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8345141184b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317404, encodeId=9480131e40407, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率, objectType=article, longId=141181, objectId=358114118169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=358114118169, replyNumber=0, likeNumber=46, createdTime=2018-06-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=358114118169, moduleTitle=Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=358114118169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317403, encodeId=9009131e40306, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：肿瘤相关静脉血栓风险的临床预测模型, objectType=article, longId=140284, objectId=c1601402847d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1601402847d, replyNumber=0, likeNumber=84, createdTime=2018-06-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1601402847d, moduleTitle=Lancet haemat：肿瘤相关静脉血栓风险的临床预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1601402847d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317402, encodeId=7a3a131e402ee, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologic：真实世界经验——NPP计划下伊布替尼治疗CLL的国际经验, objectType=article, longId=140242, objectId=1bd1140242b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bd1140242b4, replyNumber=0, likeNumber=15, createdTime=2018-06-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bd1140242b4, moduleTitle=Haematologic：真实世界经验——NPP计划下伊布替尼治疗CLL的国际经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bd1140242b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317401, encodeId=afbd131e401b2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA在英国退欧后面临高于预期的人员流失, objectType=article, longId=139850, objectId=ddf913985013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf913985013, replyNumber=0, likeNumber=63, createdTime=2018-06-04, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf913985013, moduleTitle=EMA在英国退欧后面临高于预期的人员流失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf913985013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317400, encodeId=09ef131e400fb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临, objectType=article, longId=139114, objectId=6780139114a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6780139114a0, replyNumber=0, likeNumber=66, createdTime=2018-05-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6780139114a0, moduleTitle=Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6780139114a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317399, encodeId=f1fa131e39980, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA确认AbbVie的MS药物Zinbryta的风险超过益处, objectType=article, longId=138663, objectId=4ce31386639e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ce31386639e, replyNumber=0, likeNumber=64, createdTime=2018-05-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ce31386639e, moduleTitle=EMA确认AbbVie的MS药物Zinbryta的风险超过益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ce31386639e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317398, encodeId=edd5131e398c5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：基于全基因组测序的抗原分型算法，可通过提高供-受体抗原匹配**度，减少过敏反应、改善输血预后, objectType=article, longId=138483, objectId=84a1138483bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84a1138483bc, replyNumber=0, likeNumber=66, createdTime=2018-05-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84a1138483bc, moduleTitle=Lancet haemat：基于全基因组测序的抗原分型算法，可通过提高供-受体抗原匹配**度，减少过敏反应、改善输血预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84a1138483bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317397, encodeId=3e4c131e39728, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=JAMA：Fremanezumab治疗可显著减少偏头痛的发作频率, objectType=article, longId=138392, objectId=69a9138392c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a9138392c9, replyNumber=0, likeNumber=77, createdTime=2018-05-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a9138392c9, moduleTitle=JAMA：Fremanezumab治疗可显著减少偏头痛的发作频率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a9138392c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317396, encodeId=e250131e39602, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效, objectType=article, longId=137851, objectId=9f9813e85191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9813e85191, replyNumber=0, likeNumber=58, createdTime=2018-05-12, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9813e85191, moduleTitle=J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9813e85191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317395, encodeId=5f53131e3951f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：新诊断AML的老年患者：三种疗法一较高下, objectType=article, longId=137654, objectId=472e13e65413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=472e13e65413, replyNumber=0, likeNumber=53, createdTime=2018-05-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472e13e65413, moduleTitle=Haematologica：新诊断AML的老年患者：三种疗法一较高下, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=472e13e65413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317394, encodeId=97ac131e394f4, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：比较两种即食膳食补充剂配方补充蛋白质对镰状细胞病患儿的影响, objectType=article, longId=137556, objectId=a31813e556c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31813e556c4, replyNumber=0, likeNumber=79, createdTime=2018-05-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31813e556c4, moduleTitle=Lancet Haematology：比较两种即食膳食补充剂配方补充蛋白质对镰状细胞病患儿的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a31813e556c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：输血依赖性地中海贫血幼童：早期开始去铁酮治疗是否安全有效？

2018-07-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？

2018-07-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Brit J Haematol：原发性纵隔B细胞淋巴瘤前线管理，R-CHOP vs DA-R-EPOCH

2018-07-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人

2018-07-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：地塞米松能否改善强化化疗急性髓细胞白血病患者的结局？

2018-07-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？

2018-07-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险

2018-07-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子

2018-06-26

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：CP-CML患者：伊马替尼一线治疗后尼洛替尼怎么样？

2018-06-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率

2018-06-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：肿瘤相关静脉血栓风险的临床预测模型

2018-06-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologic：真实世界经验——NPP计划下伊布替尼治疗CLL的国际经验

2018-06-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA在英国退欧后面临高于预期的人员流失

2018-06-04

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临

2018-05-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA确认AbbVie的MS药物Zinbryta的风险超过益处

2018-05-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：基于全基因组测序的抗原分型算法，可通过提高供-受体抗原匹配**度，减少过敏反应、改善输血预后

2018-05-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

JAMA：Fremanezumab治疗可显著减少偏头痛的发作频率

2018-05-19

智者为医08 (审核中...)

前往app查看评论内容

#EMA#

J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效

2018-05-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：新诊断AML的老年患者：三种疗法一较高下

2018-05-11

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：比较两种即食膳食补充剂配方补充蛋白质对镰状细胞病患儿的影响

2018-05-10

科室
- - 订阅+
  - 更多科室
工具
服务